A New Frontier in
Neurology Care
By Lisa Johnson, MSN, NP-C
Currently, cutting edge Dementia care is being
performed by Dr. Khalifa Mansour and the NeuroWellness
Institute. Dementia
and its causes need to be identified in the early stages.
Just like conditions such as diabetes and heart
disease, early intervention with dementia is critical.
Current methods of prevention and treatment can
significantly delay both the onset of symptoms and the
progression of Alzheimer’s Disease (AD).
Through a combination of family education, drug and
antioxidant therapy and lifestyle changes, the effect of
this disease can be delayed for three to six years, without
extending life expectancy.
The result is improved quality of life, reduced costs
and a lower need for both formal and informal care for
victims of this disease.
Unfortunately, dementia is
not an easy condition for either family or physicians to
deal with. Busy
primary physicians do not have the mechanisms in place to
accurately detect AD in the early stages.
In fact, detection of dementia due to AD and other
causes in the primary setting usually occurs 2 to 4 years
after symptom onset, if at all.
The Mini Mental Status
Exam (MMSE), perhaps the most popular and most widely used
assessment, is a broad but simple measure of memory,
orientation, and executive function.
Despite its past popularity, it cannot reliably
distinguish mild cognitive impairment or very mild dementia
from normal aging. The
MMSE is accurate in identifying impairment only when it has
progressed to dementia.
A new modality that aids in the subtle qualities of early
dementia can be picked up by a new computer generated
assessment tool called The MCI Screen.
This assessment showed overall accuracy of 98% with
sensitivity of 97% for mild cognitive impairment or mild
dementia, and 88% specificity for normal aging.
The MCI Screen enabled detection of early-stage
impaired patients much more accurately than other
assessments that have traditionally been used by clinicians.
This memory test is a short, accurate and non-invasive
assessment that takes approximately ten minutes and measures
your performance on a series of memory and judgment tasks.
Individuals who suspect any changes in their memory should
be tested and rechecked annually to follow any progression
and for those individuals with a family history of dementia,
checks should be started at the age of 50.
The combination of General
Neurology/General Neurosurgery, such as care in both an
ambulatory and critical care setting, with multidisciplinary
neuro-programs makes the care with Dr. Khalifa Mansour an
exceptional resource for patients and referring physicians
all over the world.
The philosophy of the
neurologists and neurosurgeons at the NeuroWellness Group is
based on the recognition that the treatment of patients with
serious illness requires more than technical expertise.
We are committed to value the compassion and
sensitivity that are an essential part of the
doctor-patient-family relationship.
We believe that attention to the continuum of care is
very important in reaching a successful outcome and that
patients and their families deserve detailed and
understandable explanations regarding their condition.
In keeping with this
mission, Dr. Khalifa Mansour and the members of this
specialized care program strive for excellence in patient
care and medical education.
Utilizing superb examination techniques, the MCI
screen, laboratory and imaging diagnostics, swift detection
of dementia in the early stages is being performed,
minimizing delay in treatment, and leading to a higher
quality of life.